Columbus, IN, United States of America

Charles Howard Mitch

This inventor holds 40 USPTO granted patents, plus 5 CIPO patents and 7 EPO patents, primarily in Opioid Receptor Antagonists. Top assignees: Eli Lilly and Company, Novo Nordisk A/s, Japan Lsi Co., Ltd.. Active years: 1990-2015.


% Patents Active = 80.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 11

Forward Citations = 384(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1990 - 1995)
  • Columbus, IN (US) (1996 - 2015)

Company Filing History:


Years Active: 1990-2015

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Opioid Receptor Antagonists
Heterocyclic Compounds
Antipsychotic Methods
Kappa Selective Antagonists
Pharmaceutical Compounds
Amino-Phenoxymethyl-Benzamide
Piperidine Antagonists
Excitatory Amino Acids
Diaryl Ethers
Indane Derivatives
Schizophrenia Treatment
Alzheimer's Disease
40 patents (USPTO):Explore Patents

Title: Charles Howard Mitch - Innovative Inventor from Columbus, IN

Introduction: Charles Howard Mitch is a renowned inventor based in Columbus, Indiana, known for his groundbreaking contributions to various industries.

Latest Patents: Charles Howard Mitch holds several patents in the fields of technology, healthcare, and automotive engineering, with his most recent inventions focusing on sustainable energy solutions.

Career Highlights: With a career spanning over two decades, Charles Howard Mitch has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized the way we live and work.

Collaborations: Throughout his career, Charles Howard Mitch has collaborated with top companies, innovative startups, and talented individuals to bring his ideas to life and make a lasting impact on society.

Conclusion: Charles Howard Mitch's passion for innovation and his dedication to creating a better future through his inventions make him a true pioneer in the world of technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…